4.7 Article

Gold nanoparticles as carriers for a synthetic Streptococcus pneumoniae type 14 conjugate vaccine

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Review Chemistry, Multidisciplinary

Nanoparticle Delivery Systems in Cancer Vaccines

Yogita Krishnamachari et al.

PHARMACEUTICAL RESEARCH (2011)

Review Chemistry, Multidisciplinary

A New Era for Cancer Treatment: Gold-Nanoparticle-Mediated Thermal Therapies

Laura C. Kennedy et al.

Editorial Material Immunology

What do the next 100 years hold for pneumococcal vaccination?

Ger T. Rijkers et al.

EXPERT REVIEW OF VACCINES (2010)

Review Biotechnology & Applied Microbiology

Glyconanoparticles: multifunctional nanomaterials for biomedical applications

Isabel Garcia et al.

NANOMEDICINE (2010)

Review Biotechnology & Applied Microbiology

Carbohydrate vaccines: developing sweet solutions to sticky situations?

Rena D. Astronomo et al.

NATURE REVIEWS DRUG DISCOVERY (2010)

Review Chemistry, Multidisciplinary

Gold nanoparticles in nanomedicine: preparations, imaging, diagnostics, therapies and toxicity

Elodie Boisselier et al.

CHEMICAL SOCIETY REVIEWS (2009)

Article Chemistry, Multidisciplinary

Gold Manno-Glyconanoparticies: Multivalent Systems to Block HIV-1 gp120 Binding to the Lectin DC-SIGN

Olga Martinez-Avila et al.

CHEMISTRY-A EUROPEAN JOURNAL (2009)

Review Chemistry, Medicinal

Carbohydrates: A Frontier in Medicinal Chemistry

Pierre Stallforth et al.

JOURNAL OF MEDICINAL CHEMISTRY (2009)

Article Biochemistry & Molecular Biology

Peptides conjugated to gold nanoparticles induce macrophage activation

Neus G. Bastus et al.

MOLECULAR IMMUNOLOGY (2009)

Article Immunology

Both Th1 and Th17 are immunopathogenic but differ in other key biological activities

Catherine A. Cox et al.

JOURNAL OF IMMUNOLOGY (2008)

Review Biotechnology & Applied Microbiology

Design opportunities for actively targeted nanoparticle vaccines

Tarek M. Fahmy et al.

NANOMEDICINE (2008)

Article Biotechnology & Applied Microbiology

Tiopronin monolayer-protected silver nanoparticles modulate IL-6 secretion mediated by Toll-like receptor ligands

Paula M. Castillo et al.

NANOMEDICINE (2008)

Article Multidisciplinary Sciences

An oligosaccharide-based HIV-1 2G12 mimotope vaccine induces carbohydrate-specific antibodies that fail to neutralize HIV-1 virions

Joseph G. Joyce et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)

Article Multidisciplinary Sciences

Targeting the carbohydrates on HIV-1: Interaction of oligomannose dendrons with human monoclonal antibody 2G12 and DC-SIGN

Sheng-Kai Wang et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)

Article Microbiology

Interleukin-17A mediates acquired immunity to pneumococcal colonization

Ying-Jie Lu et al.

PLOS PATHOGENS (2008)

Review Biotechnology & Applied Microbiology

Characterization of nanoparticles for therapeutics

Jennifer B. Hall et al.

NANOMEDICINE (2007)

Article Biochemistry & Molecular Biology

Robust immune responses elicited by a fully synthetic three-component vaccine

Sampat Ingale et al.

NATURE CHEMICAL BIOLOGY (2007)

Article Biochemistry & Molecular Biology

Preparation of multifunctional glyconanoparticles as a platform for potential carbohydrate-based anticancer vaccines

Rafael Ojeda et al.

CARBOHYDRATE RESEARCH (2007)

Article Immunology

Epidermal DNA vaccine for influenza is immunogenic in humans

Robert J. Drape et al.

VACCINE (2006)

Article Biochemistry & Molecular Biology

Block synthesis of Streptococcus pneumoniae type 14 capsular polysaccharide structures

A Sundgren et al.

JOURNAL OF CARBOHYDRATE CHEMISTRY (2005)

Review Chemistry, Multidisciplinary

Self-assembled monolayers of thiolates on metals as a form of nanotechnology

JC Love et al.

CHEMICAL REVIEWS (2005)

Article Multidisciplinary Sciences

A synthetic conjugate polysaccharide vaccine against Haemophilus influenzae type b

V Verez-Bencomo et al.

SCIENCE (2004)

Article Medicine, General & Internal

Decline in invasive pneumococcal disease after the introduction of protein-polysaccharide conjugate vaccine

CG Whitney et al.

NEW ENGLAND JOURNAL OF MEDICINE (2003)